Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders

Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders

US Patent 7635472 · Granted Dec 22, 2009

Estimated economic value: $6,790,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibody constructs for CDH19 and CD32025
Antibody constructs for CDH19 and CD32025
Antibody constructs for DLL3 and CD32025
Antibody constructs for DLL3 and CD32025
PSMA and CD3 bispecific T cell engaging antibody constructs2025
Antibody constructs for DLL3 and CD32025
Antibody constructs for DLL3 and CD32025
Antibody constructs for CDH19 and CD32025
Antibody constructs for CDH19 and CD32025
Cross-species-specific PSMAxCD3 bispecific single chain antibody2025
Cross-species-specific PSMAxCD3 bispecific single chain antibody2025
Binding molecules for BCMA and CD32025